Volume 26, Number 9—September 2020
Research
Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France
Table 4
Obstetric and neonatal outcomes for 100 pregnant women with severe acute respiratory syndrome 2 infection, France*
Obstetric outcomes |
Value |
Ongoing pregnancies | 67 (67.0) |
Stillbirths or miscarriages | 0 |
Deliveries | 33 (33.0) |
Median days between SARS-CoV-2 diagnosis and delivery (IQR) |
3 (1–9) |
Delivery mode | |
Vaginal | 17 (51.5) |
Spontaneous labor | 9 (52.9) |
Induced labor, reason | 8 (47.1) |
Respiratory degradation | 4 (50.0) |
Preeclampsia | 1 (12.5) |
Intrahepatic cholestasis | 1 (12.5) |
Reduced fetal movements | 1 (12.5) |
Premature rupture of membranes | 1 (12.5) |
Caesarean delivery, reason | 16 (48.5) |
Respiratory distress | 12 (36.4) |
Major coagulopathy | 1 (6.3) |
Severe preeclampsia | 1 (6.3) |
Non-reassuring fetal heart rate | 1 (6.3) |
Definitive cervicoisthmic cerclage |
1 (6.3) |
Gestational age at birth, wk, median (IQR) | 37.9 (35–40.1) |
>37 | 20 (60.6) |
32–36 | 13 (39.4) |
24–31 |
7 (21.2) |
Twin pregnancies | 3 (3.0) |
Neonates† |
36 |
Birthweight z-score, g, median (IQR) | 0.15 (–0.75 to 0.64) |
<10th percentile |
1 (3) |
Apgar score <7 | |
1 min | 8 (22) |
5 min | 4 (11) |
10 min |
1 (3) |
Umbilical arterial pH, median (IQR) | 7.26 (7.24–7.29) |
Neonatal intubation | 6 (17) |
NICU hospitalization | 10 (28) |
Neonatal death | 0 |
Neonate SARS-CoV-2–positive | 1 (3) |
*Values are no. (%) except where indicated. IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
†33 women gave birth, including 3 sets of twins.